. . . . . . . . . . . "path(MESHD:Ischemia) -> r(RGD:Tlr4)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "TLR4 and its partner molecule MD-2 may play an important role in Kupffer cell activation and IR injury." . . "Selventa" . . . . "2014-07-03T14:30:27.243+02:00"^^ . . .